Biotech
Pfizer halts development of experimental cancer drug in early-stage trial
Pfizer halts development of its experimental cancer drug PF-08046037 in early trials, citing strategic reasons rather than safety concerns.
S
Surya Pratap Singh
4/27/2026, 6:00:06 AM
